Ethzilla Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$3.46

+0.36 (+11.61%)

As of Feb 8, 2:16 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,295.4% upside

Low Target $28.52

Average Target $48.28

High Target $57.13

Current Price $3.46

Current
$3.46

Target
$48.28

$28.52 $48.28 avg $57.13

Scenario Analysis

Bear Case

$28.52

724.3%

Low target

Base Case

$48.28

+1,295.4%

Avg target

Bull Case

$57.13

+1,551.2%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$46.74

-92.6% from high

52-Week Low

$31.95

+-89.2% from low

Target vs 52W High

$48.28

+3.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%